Back

Clinical trial CRO

03-03-2014
Clinical trial CROClinical trial CRO
Clinical trial CROClinical trial CRO
During the development of a drug, from its initial phase to its marketing, it must go through an entire protocol of validation that allows to certify the safety and efficacy of the product. That is why, most pharmaceutical companies must contact a clinical trial CRO to conduct all the phases of the study and, thus, gather the necessary information to continue growing and providing medical solutions to the community. 

In the area of clinical trials, it has become increasingly common to find companies offering this type of service, assuming part of the risk (both financially and time-related) that this type of operation entails; thus, big pharmaceutical companies have been increasingly outsourcing part of their drug validation and verification processes to share the risks of this type of studies. 

CRO Specialist in Clinical Trials

At BioClever, we are aware of the risks involved in conducting these trials and because we are a clinical trial CRO and assume part of this risk, we can develop and offer increasingly more specific and quality solutions to our clients, and therefore keep growing and offering a better, more professional and customized service. 
In short, our goal is to offer quality services with professionalism and a guarantee of success both in the design and in the development of any projects associated with clinical trials. Thus, a clinical trial CROlike ours can always offer a service performed by qualified professionals and ensuring its quality, since our entire system is based on the implementation of quality systems in the clinical trial setting. 

Share

Related news

Regulations concerning clinical trials with drug products
20-11-2016

Regulations concerning clinical trials with drug products

At the 11th Congress held by the Medical Association of the Pharmaceutical Industry (AMIFE, as per the Spanish acronym), held on November 12-14 in Madrid, one of the issues discussed was the status of the Clinical Trial Royal Decree, which is currently awaiting the ruling of the State Council, since the text is almost finished, as stated by Mr. César Hernández, Head of the Committee on Medicinal Products for Human Use of the Spanish Agency of Medicinal Products and Medical Devices (AEMPS).
Open Clinical Trials
10-12-2020

Open Clinical Trials

An open clinical trial (CT) may have two different meanings based on the possibility of modifying the characteristics described in the study protocol or on the level of masking of the treatment or intervention administered.